A group of researchers from the University of Erlangen-Nuremberg has discovered which immune cells migrate from the skin of ...

Discover why psoriasis treatments may lose effectiveness and explore alternatives. Learn about the potential of biologics, ...

Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial ...

Experts review warning nail features, from inflammatory conditions to tumours, offering practical guidance on diagnosis and ...

Congratulations – you’ve got through Dry January! Whether you are about to reset your relationship with alcohol for the long ...

Randal Alberto Gamboa-Esquivel suffered an “unspecified psychosis," the Department of Homeland Security told Newsweek.

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in ...

Following rusfertide’s triumphant Phase III trial last year, Protagonist must decide how involved to be in future development ...

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.